OTC:CC - Ocumetics Technology Corp (OTC) To Be Featured on Radius Research's Pitch Deep Dive and Q&A Webinar (Feb 29 2024)
(TheNewswire)
Calgary, Alberta – TheNewswire - February 29, 2024 - Ocumetics Technology Corp. (“Ocumetics”)(TSXV:OTC) (OTC:OTCFF) (FRA:2QBO), is pleased to invite investors andother interested parties to attend an upcoming interview with MarketRadius Research.
Martin Gagel of Market Radius Research and CEO DeanBurns will be discussing Ocumetics’ revolutionary accommodatingintraocular lens, the successful completion of animal studies and theupcoming First in Human study.
The webinar will be a live, interactive online event whereattendees are invited to ask the Company questions in real-timefollowing the interview. An archived webcast will be made availablefor those who cannot join the event live on the day of the webinar.
Event: RadiusResearch Pitch, Deep Dive, and Q&A with Ocumetics TechnologyCorp.
Presentation Date &Time: Thursday, February 29th at 4:00 PM ET /1:00 PM PT
Webcast Registration Link: https://us02web.zoom.us/webinar/register/1317085455555/WN_jIibe93XRX6CA89hoVcSXw
About Market RadiusResearch
Market Radius Research gives individual investorsaccess to in-depth CEO interviews with deep-dive institutional leveldiscussion and Q&A. Market Radius is hosted by Martin Gagel,former top-ranked technology analyst. By registering for this webinar,you agree to receive email communications from Market Radius Capital,Inc. and from the presenting company (with unsubscribe). Your emailwill not be further shared. Martin Gagel and Market Radius Capital,Inc. are not registered or licensed to provide investment advice andmay own shares in mentioned companies and may be compensated for theseservices. Content is for information purposes only and is not adviceor recommendations and may include incomplete or incorrectinformation. Investing entails a high degree of risk. This is aproduction of Market Radius Capital, Inc.
About Ocumetics TechnologyCorp.
Ocumetics Technology Corp. ( TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QBO),headquartered in Calgary, Alberta, Canada, is an innovator in the field of ophthalmic technology, dedicated todeveloping and commercializing advanced vision correction solutionsthat enhance the quality of life for individuals worldwide.
Ocumetics is in the preclinical study stage of agame-changing technology for the ophthalmic industry. In its pursuitof a next generation interocular lens solution, Ocumetics hasdeveloped the Ocumetics Accommodating Lens, anexpandable intraocular lens that fits within the natural lenscompartment of the eye. It is designed to allow the eye’s naturalmuscle activity to seamlessly shift focus from distance tointermediate to near.
FOR FURTHER INFORMATION, PLEASECONTACT:
Dean Burns Dayton Marks
President and CEO Director
(817) 874-7564 (778)347-2500
Neither the TSXVenture Exchange nor its Regulation Services Provider (as that term isdefined in the policies of the TSX Venture Exchange) acceptsresponsibility for the adequacy or accuracy of this release.
Copyright (c) 2024 TheNewswire - All rights reserved.